Mihael Hristos Polymeropoulos, President and CEO at Vanda Pharmaceuticals Inc. (VNDA), sold 357,805 shares at $15.56 ($5.5M) on 2019-05-17, disclosed to the SEC on 2019-05-21.
Open-market sale of $5.5M VNDA by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.56 | 77,225 | $1.2M | 21.9% |
| 2 | $15.12 | 67,418 | $1.0M | 18.6% |
| 3 | $15.12 | 67,418 | $1.0M | 18.6% |
| 4 | $15.34 | 72,872 | $1.1M | 20.4% |
| 5 | $15.34 | 72,872 | $1.1M | 20.4% |
| Total | $15.30 avg | 357,805 |
| $5.5M |
| 100% |
| Filing → |
| VNDA | BUY | 2025-05-21 | $44K | — | Filing → |
| VNDA | BUY | 2025-05-19 | $84K | — | Filing → |
| VNDA | BUY | 2025-03-06 | $50K | — | Filing → |